Skip to main content
Log in

The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

To investigate whether or not a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children, we studied 8 healthy prepubertal children aged $4^{2}/{_{_{12}}} - 7^{10}/{_{_{12}}} {⤪ yr}$, whose heights were over the 95th percentile of the NCHS tables. We defined as “paradoxical” a GH increment greater than 5 ng/ml in response to TRH. Five out of 8 children showed a paradoxical response of GH to TRH (mean GH peak after TRH of 10.7 ± 1.1 ng/ml). Pretreatment with atropine (0.01 mg/kg IM 30 min prior to the TRH administration) abolished the TRH induced GH rise (peak GH after TRH of 1.5 ± 1.0 ng/ml, p < 0.01) but did not modify the TSH response (peak TSH after TRH: basal conditions 8.7 ± 0.8 μU/ml, post atropine: 9.5 ± 1.4 μU/ml, p > 0.05). Our results demonstrate that a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Leveston S.A., Cryer P.E. Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans. Metabolism 29: 703, 1980.

    Article  PubMed  CAS  Google Scholar 

  2. Mendelson W.B., Sitaram N., Wyatt R.J., Gillin J.C., Jacobs L.S. Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism. J. Clin. Invest. 61: 1683, 1978.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Delitala G., Frulio T., Pacifico A., Maioli M. Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man. J. Clin. Endocrinol. Metab. 55: 1231, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Penalva A., Villanueva L., Gasanueva F., Cavagnini F., Gomez-Pan A., Muller E.E. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33–824 in man. Psychopharmacology 80: 120, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Casanueva F.F., Villanueva L., Cabranes J.A., Cabezas-Cerrato J., Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. J. Clin. Endocrinol. Metab. 59: 526, 1984..

    Article  PubMed  CAS  Google Scholar 

  6. Massara F., Ghigo E., Goffi S., Molinatti G.M., Muller E.E., Camanni F. Blockade of hP-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 59: 1025, 1984.

    Article  PubMed  CAS  Google Scholar 

  7. Taylor B.J., Smith P.J., Brook C.G.D. Inhibition of physiological growth hormone secretion by atropine. Clin. Endocrinol. (Oxf.) 22: 497, 1985.

    Article  CAS  Google Scholar 

  8. Jordan V., Dieguez C., Lafaffian I., Rodríguez-Arnao M.D., Gomez-Pan A., Hall R., Scanion M.F. Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1–29. Clin. Endocrinol. (Oxf.) 24: 291, 1986.

    Article  CAS  Google Scholar 

  9. Anderson M.S., Bowers C.Y., Kastin A.J., Schalch D.S., Schally A.V., Snyder P.J., Utiger R.D., Wilber J.F., Wise A.J. Synthetic thyrotropin releasing hormone. N. Engl. J. Med. 205: 1279, 1971.

    Article  Google Scholar 

  10. Schalch D.S., Gonzalez-Barcena D., Kastin A.J., Schally A.V., Lee L.A. Abnormalities in the release of TSH in response to thyrotropin-releasing hormone (TRH) in patients with disorders of the pituitary, hypothalamus and basal ganglia. J. Clin. Endocrinol. Metab. 35: 609, 1972.

    Article  PubMed  CAS  Google Scholar 

  11. Irie M., Tsushima T. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J. Clin. Endocrinol. Metab. 35: 97, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Gonzales-Barcena D., Kastin A.J., Schalch D.S., Torres-Zamora M., Perez-Pasten E., Kato A., Schally A.V. Responses to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men. J. Clin. Endocrinol. Metab. 36: 117, 1973.

    Article  Google Scholar 

  13. Panerai A.E., Salerno F., Manneschi M., Cocchi D., Muller E.E. Growth hormone and prolactin responses to thyrotropin-releasing hormone in patients with severe liver disease. J. Clin. Endocrinol. Metab. 45: 134, 1977.

    Article  PubMed  CAS  Google Scholar 

  14. Maeda K., Kato Y., Ohgo S., Chihara K., Yoshimoto Y., Yamaguchi N., Kuromaru S., Imura H. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression. J. Clin. Endocrinol. Metab. 40: 501, 1975.

    Article  PubMed  CAS  Google Scholar 

  15. Maeda K., Kato Y., Yamaguchi N., Chihara K., Ohgo S, Iwasaki Y., Yoshimoto Y., Moridera K., Kuromaru S., Imura H. Growth hormone release following thyrotropin-releasing hormone injection into patients with anorexia nervosa. Acta Endocrinol. (Kbh.) 81: 1, 1976.

    CAS  Google Scholar 

  16. Collu R., Leboeuf G., Letarte J., Ducharme J.R. Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism. J. Clin. Endocrinol. Metab. 44: 743, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Dasmahapatra A., Urdanivia E., Cohen M.P. Growth hormone response to thyrotropin-releasing hormone in diabetes. J. Clin. Endocrinol. Metab. 52: 859, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Evain-Brion D., Gamier P., Schimpff R.M., Chaussain J.L., Job J.C. Growth hormone response to thyrotropin-releasing hormone and oral glucose-loading tests in tall children and adolescents. J. Clin. Endocrinol. Metab. 56: 429, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Chiodera P., Coiro V., Speroni G., Capretti L, Muzzetto P., Volpi R., Butturini U. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetes involves a cholinergic mechanism. J. Clin. Endocrinol. Metab. 59: 794, 1984.

    Article  PubMed  CAS  Google Scholar 

  20. Greulich W.W., Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist. Standford University Press, Standford, Ca. 1959.

    Google Scholar 

  21. Joel E.W., Schonberg W.I., Keller E. Problems of optimization of double antibody radioimmunoassay of hLH, hFSH and hGH. In: Radioimmunoassay and Related Procedures in Medicine, International Atomic Energy Agency, Proceedings of a Symposium, Instanbul 1: 45, 1973.

  22. Utiger R.D. Thyrotropin. In: Jaffe B.M. and Behrman H.R. (Eds.), Methods of hormone radioimmunoassay. Academic Press, New York, 1974, p 161.

    Google Scholar 

  23. Evans P.J., Dieguez C., Foord S., Peters J.R., Hall R., Scanion M.F. The effects of cholinergic blockade on the growth hormone and prolactin response to insulin hypoglycaemia. Clin. Endocrinol. (Oxf.) 22: 733, 1985.

    Article  CAS  Google Scholar 

  24. Garcia Blanco M., Evain-Brion D. Studies in constitutionally tall adolescents: Somatostatin decrease associated with growth hormone increase after TRH injection. Clin. Endocrinol. (Oxf.) 21: 459, 1984.

    Article  Google Scholar 

  25. Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.

    Article  PubMed  CAS  Google Scholar 

  26. Tannenbaum G.S., Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115: 1952, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Hindmarsh P.C., Pringle P.J., Brook C.G.D. Cholinergic muscarinic blockade produces shortterm suppression of growth hormone secretion in children with tall stature. Clin. Endocrinol. (Oxf.) 29: 289, 1988.

    Article  CAS  Google Scholar 

  28. Evain-Brion D., Garnier P., Blanco-García M., Job J.L. Studies in constitutionally tall adolescents. II. Effects of bromocriptine on growth hormone secretion and adult height prediction. J. Clin. Endocrinol. Metab. 58: 1022, 1984.

    Article  PubMed  CAS  Google Scholar 

  29. Schoenle E.J., Theintz G., Torresani T., Prader A., Illig R., Sizonenko P.C. Lack of bromocriptine-induced reduction of predicted height in tall adolescents. J. Clin. Endocrinol. Metab. 65: 355, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by grant PG 7/85, School of Medicine, Catholic University of Chile and grants from Comisión Nacional de Investigación Cientffica y Tecnológica (CONICYT 533/85) and Dirección de Investigación de la Universidad Católica de Chile (DIUC 102/85). It was presented as an abstract at the 69th Annual Meeting of the Endocrine Society, Indianapolis, 1987 (abstract no 931).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arteaga, E., Valenzuelaa, P., Cattani, A. et al. The paradoxical response of growth hormone (GH) to thyrotropin-releasing hormone (TRH) in constitutionally tall children involves a cholinergic pathway. J Endocrinol Invest 12, 543–548 (1989). https://doi.org/10.1007/BF03350756

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350756

Key-words

Navigation